Metabolic enzyme ACSL3 is a prognostic biomarker and correlates with anticancer effectiveness of statins in non-small cell lung cancer

  1. Fernández, L.P.
  2. Merino, M.
  3. Colmenarejo, G.
  4. Moreno-Rubio, J.
  5. Sánchez-Martínez, R.
  6. Quijada-Freire, A.
  7. Gómez de Cedrón, M.
  8. Reglero, G.
  9. Casado, E.
  10. Sereno, M.
  11. Ramírez de Molina, A.
Aldizkaria:
Molecular Oncology

ISSN: 1878-0261,  1574-7891

Argitalpen urtea: 2020

Alea: 14

Zenbakia: 12

Orrialdeak: 3135-3152

Mota: Artikulua

DOI: 10.1002/1878-0261.12816 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus